Landmark trial RTOG1205 reirradiation recurrent #GBM •Small GTVs 18 cc •80% 1st relapse •Significant PFS benefit, important clinically if options limited •No OS benefit possibly due to salvage RT on Bev alone arm •Link: ascopubs.org/doi/full/10.12… #roedu

David Mak, MD JTO & JTO CRR Alex Louie MD, PhD Michael Tjong Sunnybrook Health Sciences Centre David, I'm glad you highlighted the benefits of adding RT to osimertinib to improve survival. Something that occurs less often when adding other drugs to osimertinib. Jill Feldman Ivy Elkins H. Jack West, MD, FASCO Nathan A. Pennell MD, PhD, FASCO Jarushka Naidoo Charu Aggarwal, MD, MPH, FASCO Suresh S. Ramalingam, MD, FASCO

Radiosurgery for Refractory Depression likely saved the lives of patients who participated in this IRB-approved clinical trial. Treatment target = bilateral anterior limb of the internal capsule) #radonc sciencedirect.com/science/articl…

Published “Top 10 Lessons Learned from Trials in Oligometastatic Cancers” in CRT reviewing #SABR outcomes, toxicity, costs, combination with systemic therapies and barriers to accrual for trials David Palma, MD, PhD #radonc #onctwitter #medtwitter e-crt.org/journal/view.p…

🎞️Announcing the newly updated Caring for Your Tracheostomy video series! This 8 part video series will assist patients who have a #tracheostomy because of head and neck surgery and/or a head and neck cancer diagnosis. View the videos on YouTube: youtube.com/playlist?list=…

Excellent 🏀 outing for the UofT Radiation Oncology Residents #radonc PAs and fellows courtesy of Radiation Medicine Program, with a shoutout on the jumbotron for our Princess Margaret Cancer Centre group!

R&O: "Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial" ift.tt/t6goV2Z

For those who don’t match this week…

.UofT Radiation Oncology Residents had a ⚾️ at the Toronto Blue Jays game with our Radiation Medicine Program friends! Can’t wait for the next social 😊 Laura Dawson David Kirsch, MD, PhD Joanna Javor David Mak, MD Inhwa Kim Radiation Oncology

Fun to meet amazing @UTDRO #radonc residents at the Toronto Blue Jays game today. Bonus to chat with Laura Dawson about Radiation Medicine Program Princess Margaret Cancer Centre University Health Network and Joanna Javor about the critical role CSRTs can play in caring for cancer patients in #radonc

📢 We're thrilled to announce that Derek Tsang, a renowned radiation oncologist, will be attending #SIOPcongress in Canada. 🗓️ Don't miss his lecture on cutting-edge advancements in #radiotherapy. Save the date! ➡️ bit.ly/43fPQPH Derek Tsang #RadiationOncology

60F w/ EGFR+ (Ex21) synch oligomet NSCLC #lcsm: 1.5 cm 🫁 primary, 0.4 cm asymp 🧠 met, painful 🦴met. To start Osi. #radonc consulted. 🧐 What would Andrea Bezjak and I (Radiation Oncology Radiation Medicine Program) do? 🗣️ Hammer Wisely ☢️🔨🦀! Now in ASTRO IJROBP - The Red Journal #gyzone: tinyurl.com/523t82vr

Another Canadian collaborative study, thanks to Farshad Nassiri gelareh-zadeh Alex Landry Derek Tsang Andrew Gao and Stephen Yip, MD/PhD FRCPC Sunit Das Dr. Michael D. Cusimano Alex Rebchuk Serge Makarenko, David Munoz, Julian Spears University Health Network University of Toronto Neurosurgery University of British Columbia Unity Health Toronto sciencedirect.com/science/articl…

The new OncoScan is populated by IROCK stars! 😎 "Radiation Therapy for Renal Cell Carcinoma" - what to know about renal masses, how to SBRT them, +/- systemic therapy. 🥷Who says we don't have new indications?🥷 Nicholas Zaorsky, MD MS Alex Louie MD, PhD Shankar Siva redjournal.org/article/S0360-…

#ASPIRE-ILD for #SABR in ILD 🫁 presented at #ASTRO2023 David Palma, MD, PhD Alex Louie MD, PhD Houda Bahig, MD PhD #radonc #onctwitter ✅ 50Gy/5#, 1 year OS 79%, met toxicity thresholds

Vivian Tan MD presenting 5-year clinical outcomes for patients with solitary vs bilateral kidneys treated with SBRT at #ASTRO2023. SBRT safe and effective for RCC, even with solitary kidneys. 👏👏Compelling study!! Rohann Correa Shankar Siva Alex Louie MD, PhD

Congrats to our Radiation Oncology PGY5 residents Badr Id Said, David Mak, Amir Safavi, and Marissa Sherwood for passing their Royal College oral exams. Thanks to all who supported them on this journey. Join us on June 10, 2024, for the #UTDRO Graduation ceremony! Laura Dawson Temerty Medicine

Uncovering the armpit of SBRT - in this 🌎's first case series reported from Sunnybrook Health Sciences Centre - we describe our teams experience for the unique target of axillary 🦾metastases #radonc ☢️⚡️ ctro.science/article/S2405-…

❤️ to Marissa Sherwood Badr Id Said, MD David Mak, MD, my Radiation Oncology co-residents & friends for life. You make the world a better place & excited for next steps after grad! 🌊🤠🗽👶🏻 🙏 Alex Louie MD, PhD & Andrea Bezjak, dear #radonc mentors Sunnybrook Health Sciences Centre & Radiation Medicine Program 📸: fellow grad Marc Vincent Barcelona, MD, FPCR, DPBR-RO!

🎓Hats off to our Radiation Oncology Class of 2024 Post-Graduate Trainees for their outstanding achievements and hard work! We know you'll make a positive impact on the world. #UofTGrad24 🎉Explore the list of graduands and award winners: bit.ly/45l2IpY Laura Dawson